Cell and Gene Therapy

The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.


 

Cell and Gene Therapy
24/11/2020

Optimising the transfection process and its efficiency is paramount to boosting vector titres during scale-up and manufacturing of AAV vectors with new generation transfection reagents